Cover Image
市場調查報告書

EpiCast Report:偏頭痛的流行病學的預測

EpiCast Report: Migraine - Epidemiology Forecast to 2023

出版商 GlobalData 商品編碼 296020
出版日期 內容資訊 英文 44 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:偏頭痛的流行病學的預測 EpiCast Report: Migraine - Epidemiology Forecast to 2023
出版日期: 2014年02月10日 內容資訊: 英文 44 Pages
簡介

全球主要7個國家偏頭痛的患病人數,2013年為7638萬人,2023年為7583萬人,預計持續維持與現在同樣的水準。美國的患病人數最多,2013年為2961萬人,2023年推算為3113萬人。

本報告提供全球主要7個國家(美國、法國、德國、義大利、西班牙、英國、日本)的糖尿病神經病變的發病情形和今後預測相關分析、疾病的特徵(風險要素和主要的共生病症等等)全球各國的趨勢、目前患病者的發病情形、今後10年的患病數量的預測值等調查評估,並將其結果依為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 概要

第3章 流行病學

  • 疾病的背景
  • 風險要素和共生病症
    • 女性和有無家族病史,有風險要素相關性
    • 偏頭痛患者也患有其他幾個共生病症
  • 全世界的趨勢
    • 美國
    • 歐洲主要5個國家
    • 日本
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 偏頭痛的流行病學預測(今後11年份)
    • 偏頭痛的患病人數:總數
    • 偏頭痛的患病人數:各年齡
    • 偏頭痛的患病人數:男女
    • 偏頭痛的患病人數(已調整年齡)
    • 偏頭痛的患病人數:如果沒有徵兆的情況
  • 議論
    • 流行病學性的趨勢相關結論
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表一覽

目錄
Product Code: GDHCER054

Migraine is typically characterized by recurring headaches, throbbing pain on one side of the head along with one or more of the following symptoms: nausea; vomiting; and increased sensitivity to light, sound and smell (Bigal and Lipton, 2006). Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the condition worldwide, and it is therefore recognized as a high-priority public health problem by the World Health Organization (WHO) (Leonardi et al., 2005; Lusic, 2001). The Global Burden of Disease (GBD) study in 2010 ranks migraine as the first among the neurological disorders (Leonardi and Raggi, 2013).

In 2023, GlobalData epidemiologists forecast that the total prevalent cases of migraine in the 7MM remained almost the same, with 75.83 million total prevalent cases in 2013 and 76.38 million total prevalent cases, with an annual growth rate (AGR) of 0.07% in the forecast period. Throughout the forecast period, the US will have the highest number of total prevalent cases of migraine, with 29.61 million total prevalent cases in 2013 and 31.13 million total prevalent cases in 2023.

GlobalData epidemiologists obtained total prevalence data for migraine from peer-reviewed journals and population-based studies in the respective markets and used consistent methodology to ensure comparability of results. Furthermore, GlobalData epidemiologists made a meaningful assumption that the age- and sex-specific total prevalence of migraine in the 7MM would remain constant throughout the forecast period because epidemiologic literature suggests relatively stable trends in the prevalence of migraine worldwide, thereby providing a realistic and meaningful forecast for the age- and sex-specific total prevalent cases of migraine in the 7MM.

Scope

  • The Migraine EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of migraine in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases of migraine segmented by age (beginning at 18 years and ending at 80 years and older), sex, and the number of total prevalent cases of migraine with aura and without aura in these markets.
  • The migraine epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global migraine market.
  • Quantify patient populations in the global migraine market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for migraine therapeutics in each of the markets covered.
  • Identify the number of migraine cases with aura and without aura.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
    • 3.2.1. Female sex and family history are interrelated risk factors of migraine
    • 3.2.2. People with migraine also suffer from several comorbidities
  • 3.3. Global Trends
    • 3.3.1. US
    • 3.3.2. 5EU
    • 3.3.3. Japan
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods
  • 3.5. Epidemiological Forecast for Migraine (2013-2023)
    • 3.5.1. Total Prevalent Cases of Migraine
    • 3.5.2. Age-Specific Total Prevalent Cases of Migraine
    • 3.5.3. Sex-Specific Total Prevalent Cases of Migraine
    • 3.5.4. Age-Standardized Total Prevalence of Migraine
    • 3.5.5. Total Prevalent Cases of Migraine with Aura and Migraine without Aura
  • 3.6. Discussion
    • 3.6.1. Conclusions on Epidemiological Trends
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Epidemiology and Health Policy
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for Migraine
  • Table 2: Prevalence of the Most Frequent Comorbidities in People with and without Migraine, Ages ≥18 Years, Both Sexes
  • Table 3: One-Year Total Prevalence (%) of Migraine in the 5EU
  • Table 4: Lifetime Total Prevalence (%) of Migraine in the 3EU
  • Table 5: Criteria Proposed by the Second Edition of the International Classification of Headache Disorders (ICHD-2)
  • Table 6: Epidemiological Sources of Total Prevalence Data Used in the Analysis for Migraine and its Subtypes (Migraine with Aura and Migraine without Aura)
  • Table 7: 7MM, Total Prevalent Cases of Migraine, Ages ≥18 Years, Both Sexes, N, 2013-2023
  • Table 8: 7MM, Total Prevalent Cases of Migraine, by Age, Both Sexes, N, (Row %), 2013
  • Table 9: 7MM, Total Prevalent Cases of Migraine, by Sex, Ages ≥18 years, N (Row %), 2013
  • Table 10: 7MM, Total Prevalent Cases of Migraine with Aura and Migraine without Aura, Ages ≥18 Years, Both Sexes, N, Row (%), 2013

List of Figures

  • Figure 1: 7MM, Total Prevalent Cases of Migraine, Ages ≥18 Years, Both Sexes, N, 2013-2023
  • Figure 2: 7MM, Total Prevalent Cases of Migraine, by Age, Both Sexes, N, 2013
  • Figure 3: 7MM, Total Prevalent Cases of Migraine, by Sex, Ages ≥18 Years, N, 2013
  • Figure 4: 7MM, Age-Standardized Total Prevalence of Migraine, Ages ≥18 Years, 2013
  • Figure 5: 7MM, Total Prevalent Cases of Migraine with Aura and Migraine without Aura, Ages ≥18 Years, Both Sexes, N, Row (%), 2013
Back to Top